Inhalation is an important exposure route for volatile water contaminants, including disinfection by-products (DBPs). A controlled human study was conducted on six subjects to determine the respiratory uptake of haloketones (HKs) and chloroform, a reference compound, during showering. Breath and air concentrations of the DBPs were measured using gas chromatography and electron capture detector during and following the inhalation exposures. A lower percentage of the HKs (10%) is released from shower water to air than that of chloroform (56%) under the experiment conditions due to the lower volatility of the HKs. Breath concentrations of the DBPs were elevated during the inhalation exposure, while breath concentrations decreased rapidly after the exposure. Approximately 85-90% of the inhaled HKs were absorbed, whereas only 70% of the inhaled chloroform was absorbed for the experiment conditions used. The respiratory uptake of the DBPs was estimated using a linear one-compartment model coupled with a plug flow stream model for the shower system. The internal dose of chloroform normalized to its water concentration was approximately four times that of the HKs after a 30-min inhalation exposure. Approximately 0.3-0.4% of the absorbed HKs and 2-9% of the absorbed chloroform were expired through lung excretion after the 30-min exposure. The inhalation exposure from a typical 10-15 min shower contributes significantly to the total dose for chloroform in chlorinated drinking water but only to a moderate extent for HKs.
Introduction
Disinfection of drinking water is an effective water treatment process to prevent the transmission of waterborne infectious diseases. Chlorination has been the most commonly used method to disinfect water in the United States. Chlorination of surface and groundwater produces a wide range of disinfection by-products (DBPs) due to the reactions of hypochlorous acid and hypochlorite with the natural organic matter (NOM), humic and fulvic acids (Rook, 1974) . Haloketones (HKs), one of the prevalent DBP classes, have been demonstrated to be genotoxic in bacterial systems (Curieux et al., 1994) . Therefore, potential health risk may be associated with human exposure to these compounds.
Studies suggest that inhalation uptake of volatile DBPs such as chloroform in drinking water during showering can be an important exposure route (Jo et al., 1990a, b; Weisel and Jo, 1996) . A significant amount of two HKs, 1,1-dichloropropanone (DCP) and 1,1,1-trichloropropanone (TCP), is transferred from water to air during a shower (Xu and Weisel, 2003) . A 10-min shower can result in a potential inhalation exposure that contributes greater than 10% of the daily ingestion doses of the HKs (Xu and Weisel, 2003) . No human studies have been previously reported to evaluate the respiratory uptake of HKs during water usage.
In our preliminary studies, we examined the concentrations of DCP and TCP in both urine and exhaled breath as the potential biomarkers of the HKs during and following inhalation exposure. Very low HK concentrations in urine samples percluded using urinary concentrations of the HKs as biomarkers of exposure . However, the exhaled breath concentrations of HKs were more consistent, had less chromatographic interferences and provided greater time resolution than urinary measurement. Breath measurements have been extensively used as biomarkers of exposure to volatile DBPs such as trihalomethanes (summarized in Wallace, 1997) . It is also possible to estimate the body burden of volatile contaminants based on breath measurements assuming a dynamic equilibrium between the VOC concentration in alveolar air and pulmonary blood (Gordon et al., 1992; Weisel et al., 1992; Wallace et al., 1993) .
The objectives of the present study were: (1) to measure the HK concentrations in exhaled breath of human subjects during and following inhalation exposure in a shower stall:
and (2) to estimate the magnitude of dose associated with the inhalation exposure route during showering for the HKs using linear compartmental pharmacokinetic models. Chloroform was also studied as a reference compound.
Materials and methods

Human Subjects
Six subjects participated in the study (Table 1) . Since exposure to DBPs could occur in the environment, several precautions were taken to minimize their background breath level. Each subject was instructed to use bottled water for drinking and food preparation, asked not to go swimming, nor to visit places that use chlorinated solvents on the day of and prior to participating. The subjects were also requested not to shower or bathe in chlorinated water the morning of the exposure session. The study protocol was reviewed and approved by the IRB committee of the University of Medicine and Dentistry of New Jersey. Informed consent was obtained from each subject.
Shower System
The shower system used to deliver the water containing the desired DBP concentrations has been described previously (Xu and Weisel, 2003) . The target water concentrations of haloketones and chloroform were 25 and 15 mg/L respectively. Water samples were collected at 5 and 26 min after the exposure started and analyzed for HKs and chloroform by GC/ECD. While 25 mg/L is greater than the average concentration of any of the individual haloketones measured in water distribution systems, it represents a realistic upper limit of HKs that would be present in a poorly controlled water system (Clemens and Scholer, 1992) . For chloroform, a concentration of 15 mg/L is lower than its concentration in many chlorinated drinking water systems (Krasner et al., 1989) . Exposures of the magnitude and duration used do not present any known health risk to the general healthy population.
A plastic shower curtain was used to cover the opening between the shower stall and bathroom to minimize the air exchange rate in the shower stall. An additional plastic shower curtain was placed within the shower stall to divide it into two parts since the shower stall had an elongated length (2.67 m). This reduced the dilution of air within the section of the shower stall in which the subject showered. The portion of the shower stall containing the shower had a volume of 2.92 m 3 (1.30 m (length) Â 0.94 m (width) Â 2.39 m (height)). The shower water temperature was set to its maximum value, approximately 38711C. The water stream was adjusted to a fine spray to promote volatilization of chemicals from the shower water. The flowrate of the shower water was monitored in each experiment.
Inhalation-only Exposure and Sampling
Both inhalation and dermal exposures of water contaminants may occur during showering. In the present study, we isolated inhalation exposure from dermal exposure to evaluate the respiratory uptake. Individual subjects were exposed to the target DBPs in the shower air while standing near the shower water stream. The subjects wore water-proof clothing and shoes during the experiment to avoid dermal contact with the water. Prior to the exposure, the shower water was turned on for a few minutes to allow the water temperature to stabilize. After the subject entered the shower stall, the syringe pump was started to deliver the haloketones and chloroform at the target concentrations in the shower water.
The breath samples were collected at 10, 15, 20, and 25 min during the exposure with a sampling duration of 1 min. Alveolar breath was collected based on the method developed by Raymer et al. (1990) . The subject inhaled the air through his or her mouth through a one-way respiratory valve and exhaled the expired air into a polyethylene tube (B1 L) from which it was continually withdrawn onto a Tenax trap at a nominal flow rate of 1 L/min using a personal air sampling pump (SKC, Inc., Eighty Four, PA, USA). The trap was packed with Tenax TA (60-80 mesh, Supelco, Inc., Assume the unit blood volume for the population is 78.377.9 mL/kg (Heinicke et al., 2001 ). c The tidal volumes are estimated using Radford nomogram for a breathing frequency of 15 breaths/min (Comroe, 1974 Bellefonte. PA, USA) and preconditioned as described previously (Xu and Weisel, 2003) . The inspired air was not purified so no discontinuity in the exposure occurred. The actual flow rate was measured using an in-line Dry-Cal primary calibrator (SKC, Inc.) Breathing zone shower air samples were collected simultaneously to the breath samples using Tenax adsorbent traps. The air sampling traps were placed at the inlet of the breath sampler. The sampling flow rate was set to approximately 100 mL/min using a low flow adapter (SKC, Inc.) and the sampling duration was 1 min.
Breath samples were also collected at 5 and 10 min before exposure to determine the background of the DBPs in the breath of the subject. After the exposure, breath samples were collected at the time points of 1, 5, 10, 15, 30, 60, and 120 min. Pre-and post-exposure breath samples were collected in a room where the inhalation exposure to the DBPs was minimum with a sampling duration of 2 min. The inhaled air was purified with charcoal filters during the postexposure sampling period.
Analysis of Samples
The air and breath samples were analyzed with a HewlettPackard 5890 gas chromatography-electron capture detector system (GC-ECD) after being desorbed on an automated thermal desorption system (ATD-400. Perkin-Elmer Corporation. Norwalk, Connecticut, USA) at 2501C (Xu and Weisel, 2003) . The chromatographic separation was performed on a 60 m Â 0.25-mm i.d., 1-mm film thickness DB-5 capillary column (J & W Scientific, Folsom, CA, USA). The temperature program was: an initial temperature of 1001C for 5 min: a ramp to 2001C at 101C/min, with the final temperature held for 10 min to remove residual compounds from the GC column. The DBPs were identified based on the retention times. The quantification of the DBPs was achieved by comparing the peak areas of the DBPs in samples to external standards. The air and breath concentrations were calculated by dividing the amount of the haloketones on the trap by the volume of breath or air sampled through the trap. The water samples were analyzed by GC/ECD after MTBE extraction .
Blood/air Partition Coefficient
The blood/air partition coefficient is an important parameter when estimating inhalation exposure to volatile chemicals. Partition coefficient values of DCP and TCP were determined using the vial-equilibration method (Gargas et al., 1989; Vinegar et al., 1994) . A literature value was used for chloroform (Corley et al., 1990) . Human blood samples were collected from Subject A to determine the blood/air partition coefficient. A volume of 1 mL blood was placed in a 10-ml glass headspace autosampler vial (Fisher Scientific Company, Pittsburgh. PA, USA), and incubated while being mixed for 15 min at 371C to allow for equilibration. Empty reference vials were prepared at the same time. Each vial was sealed using an aluminum cap containing a Teflon-coated silicon septum (Fisher Scientific Company. Pittsburgh, PA, USA).
One mL of HK vapor from a 400 ng/ml dilution bottle was injected into the blood sample and reference vials resulting in a concentration of 40 mg/l. Separate sets of samples were incubated and shaken periodically for 1, 2, 4, and 6 h to determine the time required to reach equilibration for TCP and DCP. A minimum of five samples and five reference vials were prepared for each time point. A measure of 1 mL of the headspace from the reference vial and the sample vial was analyzed by GC/ECD with a headspace sampler (HP 19395A) connected in a split injection mode. The blood/air partition coefficient (P blood/air ) was calculated from:
where C ref the chemical concentration in the headspace of the reference vial. C sam is the headspace concentration of the sample vial, and V vial and V blood are the volumes of an empty vial and the blood, respectively.
Data Analysis
Linear compartment models have been developed to describe breath concentrations during and following exposure to volatile organic chemicals assuming a constant or linearly increasing breathing zone air concentration (Wallace et al., 1993) . The air concentration of volatile organic chemicals released from shower water is usually modeled by the plug flow stream model due to the exponential increase of the air concentrations of VOCs in a shower stall (Chinery and Gleason, 1993) . The linear compartment models developed by Wallace et al. (1993) describing an inhalation absorption and elimination of volatile chemicals during and following an inhalation exposure were modified by adding a shower model component to describe the source term.
The one-compartment model depicts the body as a simple, kinetically homogeneous compartment. Inhaled vaporized chemicals are assumed to be instantaneously transferred into pulmonary blood in the lungs and can be modeled as an equilibrium system (Wallace et al., 1993) . The exhaled alveolar air equilibrates with the blood according to the blood/air partition coefficient. Assuming complete and instantaneous mixing of pulmonary blood and the body blood, the elimination of chemicals in the blood can be characterized as a first-order process.
The mass balance in the blood compartment is represented by an ordinary differential equation (ODE), which includes the rate of respiratory uptake (Q alv (C air (t)ÀC alv (t))) and elimination of chemicals in the blood compartment:
where C blood is the DBP concentration in the blood compartment (ng/L). Q alv is the alveolar inhalation rate (L/min). C alv and C air are the DBP alveolar air concentration and shower air concentration, respectively (ng/L or mg/m 3 ). k t is the elimination rate of the DBP in blood compartment (min À1 ), and V blood is the volume of body blood (L). The elimination rate (k e ) may characterize the overall elimination process of a chemical in the blood which includes biotransformation, urinary and biliary excretion, etc.
Based on the assumption that an equilibrium between alveolar air and blood is reached instantaneously, the blood concentration can be related to the alveolar air concentration as C blood ¼ P blood/air C alv . Therefore, the mass balance equation of the blood compartment can be rewritten as
The DBP air concentration in a shower stall is characterized by the plug flow stream model (Chinery and Gleason, 1993; Xu and Weisel, 2003) . The mass balance equation in the shower stall is
where V shower is the volume of the shower (m 3 ). Q wat is the shower water flow (L/min). p vap is the weight fraction volatilized from the shower water (transfer efficiency). k air is the shower air exchange rate (min 
Note that when t-N, C alv ¼ f ss C air ss . f ss and C air ss are defined as the fraction of the inhaled DBPs that is exhaled and the air concentration at steady state, respectively, k is the elimination rate including the expired air excretion (min
À1
). According to the experimental design, once the inhalationonly exposure was completed, the subject left the shower stall as soon as possible and went into an area not impacted by releases from chlorinated water and had either nondetectable levels of DBPs or concentrations below the the background levels of exhaled breath. The DBP air concentration is therefore assumed to be zero during the postexposure period. The breath concentration during this time period is obtained by solving Eq. (2) again assuming C air ¼ 0 as follows:
where the C alv max is the DBP breath concentration upon completion of the exposure. Residence time (t), the reciprocal of the total elimination rate k, is defined as the time required for the concentration to decrease to 1/e of the initial concentration (min).
In addition to the blood compartment, a two-compartment model often includes a peripheral compartment into which all poorly perfused tissues (e.g., muscle, fat, and lean tissue) are lumped together (Wallace et al., 1993) . Exact solutions of the concentrations in the blood and peripheral compartments have been given by Wallace et al. (1993) assuming a constant air concentration during exposure. The solutions are somewhat complicated if the air concentration follows an exponential increase, and are not given in this paper. The approximate breath concentration during the postexposure period, however, can be described by a biexponential equation assuming zero air concentration for DBPs (Wallace et al., 1993) C alv ðtÞ ¼ Ae
where t 1 and t 2 are the residence times of the chemical in the blood and peripheral compartments. The sum of A and B (A þ B) is the breath concentration when the exposure ends (t ¼ 0). Significant variability in the time/concentration profile has been recognized in population pharmacokinetics studies. Variability in pharmacokinetic parameter estimates includes random-effects variability, random differences between measured observations and individual model predictions, and fixed-effects (intersubject) variability, that is variability among individuals in a study population (Sheiner and Beal, 1980a, b; Pinheiro and Bates 2000) . The population means of the one compartment parameters, t and C alv max , and the random-and fixed-effects variability of the population estimates were estimated by a nonlinear mixed-effects model (NLME, maximum likelihood algorithm, S-plus 2000) using the single exponential equation for postexposure breath concentrations (Eq. (9)).
The blood residence time ''t'' can be also estimated using the uptake-phase breath concentrations and the vapor-phase DBP concentrations during inhalation exposure based on the model developed by Wallace et al. (1993) . According to Eqs. (6) and (8), the blood residence time is a function of the steady-state expired fraction, blood/air partition coefficient, inhalation rate, and blood volume as follows:
The parameters in the biexponential equation (Eq. 10) were also estimated by pooling the data for all subjects together since the postexposure breath data for each individual were too scattered to achieve convergence.
The inhalation absorption dose during exposure was estimated for an individual subject as
where C air (t) and C alv (t) were calculated based on Eqs. (4) and (5).
Results
Water and Breathing-zone Air Concentrations of DBPs
The DBP concentrations of shower water and breathing zone air are summarized in Table 2 . The air concentrations of the DBPs in the shower stall increased rapidly after the shower water was turned on and appeared to approach a steady state during the sampling period (Figure 1 ). Based on the onecompartment plug flow stream model (Eqs. (3) and (4)) the air exchange rate (k air ) and the transfer efficiencies (p vap ) of chloroform, DCP, and TCP were estimated using nonlinear regression of the measured time series of air concentrations for each subject on the sampling times (S-plus 2000). As shown in Table 2 , the estimated overall air exchange rate was 0.15-0.18 min À1 , which agrees with the air exchange rate measured without a subject in the same shower stall (0.1470.03 min
À1
) (Xu and Weisel, 2003) . The average transfer efficiency values for chloroform, DCP, and TCP were 0.56, 0.11, 0.10, respectively. The estimated transfer efficiencies of DCP and TCP were comparable to our previous estimates, 0.17 for DCP and 0.11 for TCP (Xu and Weisel 2003) . The transfer efficiency of chloroform during showering estimated by Chinery and Gleason (1993) was 0.61, similar to our estimate.
Breath Concentrations of DBPs
The breath concentrations of chloroform, DCP, and TCP were measured before, during, and after inhalation exposure. The grand mean of the background chloroform breath concentration for all six subjects was 1.3370.42 mg/m 3 , DCP and TCP were only detected in the pre-exposure breath samples of Subjects A and E, respectively. The background concentration of TCP for Subject A was 0.0570.01 and 0.5 mg/m 3 for DCP for Subject E. The breath concentrations of each individual were corrected by subtracting the average DBP breath background for that individual. This correction assumes the breath background concentration of the DBPs is constant throughout the experimental period. During the inhalation exposure, the breath concentrations of chloroform, DCP, and TCP increased rapidly (Figure 2) . The breath concentrations of DCP and TCP appeared to approach a steady state 10 min after the exposure started. The concentration of breath chloroform during inhalation exposure varied by a factor of two even though the air concentration variations were less than a factor of 2. Once the subjects left the bathroom, the breath concentrations of the the HKs decreased exponentially to the original background levels within 2 h, while the breath concentrations of chloroform were still slightly higher than the background level at 2 h after exposure (Figure 3) . The HKs breath concentration decay curve appears to decline more rapidly than chloroform, possibly indicating a more rapid metabolism rate. 
Blood/air Partition Coefficient
To assess the blood/air partition coefficient it is necessary for the headspace HK and blood HK to be in equilibrium. For the conditions used, equilibrium was reached within 2 h. The blood/air partition coefficients are 27.571.5 (N ¼ 8) for DCP and 51.373.8 (N ¼ 8) for TCP. The blood/air partition coefficients of the HKs were measured at an air concentration of 40 mg/m 3 in the reference vial, which was three orders of magnitude higher than the actual air concentration in a shower stall. The higher concentration was selected to provide sufficient compound for the sensitivity of the headspace sampler/GC system. A split GC injection mode had to be used to obtain a good peak shape, resulting in the headspace detection limit of the system for HKs of only approximately 1 mg/m 3 . Theoretically, the blood/air partition coefficient is independent of the air concentration.
Inhalation Absorption during Showering
The percent of the inhaled volatile organic compounds absorbed across the lung-blood capillary barrier was calculated from the difference between the expired breath concentration and the air concentration collected simultaneously at each sampling time during exposure (Xu, 2002) . Approximately 85-90% of the inhaled DCP and TCP were absorbed through the lung barrier while between 40% and 80% of the chloroform was absorbed. The variation in the percentage might be a result of variability among the subjects and variations in the time when the measurements were made relative to the start of the exposure. To examine if the factors, time, subject, and compound, significantly affected the percentage of DBP absorbed, a three-factor factorial analysis was applied to the percentage data as implemented in SAS 8.01 (PROC 'GLM', SAS Institute, NC, USA). The P-values for time, subject, and compound effects were 0.79, 0.16, and o0.001, respectively. This indicated that from 10 to 25 min after the shower started, neither the time nor the subject effects were statistically significant factors affecting the percentage of the DBP absorbed during showering (a ¼ 0.05), while the absorption percentages of chloroform, DCP, and TCP during showering differed significantly. The multiple comparison (Scheffe's, a ¼ 0.05) on the compound effect suggested that although there was no statistical difference between the absorption percentages of DCP and TCP, the absorption percentage of chloroform is significantly different than those of the HKs. The overall means of the percentage absorbed for chloroform. DCP, and TCP are 71%, 86%, and 89%, respectively. Therefore, DCP and TCP in vapor phase are absorbed through the lung barrier more efficiently than chloroform, consistent with their greater water (or blood) solubility.
Discussion
Residence Time
Based on the one-compartment model, the population mean values of the blood residence time for chloroform, DCP, and TCP were 13.1, 6.25, and 5.96 min, respectively (Table 3) . The values of the random-effects variability in residence times for the HKs are approximately two times greater than the corresponding fixed-effects variability estimate. For chloroform, variation in random effects is comparable to the variation in fixed-effects (Table 3) .
A peripheral compartment, which includes organs or vessel-rich tissues and exchanges directly with the blood compartment, is usually used along with the central blood compartment to describe the postexposure breath concentration profile (Wallace et al., 1993) . A few inhalation studies have shown a clear biexponential decline for chloroform (Gordon et al., 1988 (Gordon et al., , 1992 Wallace et al., 1997) . Therefore, a biexponential decay process may be more appropriate for describing the chloroform breath concentration profile after exposure although the parameter estimates for the second exponential term are not statistically significant (Table 3) . Based on the two-compartment model fit of the decay phase data, the mean residence time for the blood compartment (t 1 ) is one-half of the one-compartment estimate for chloroform, whereas the residence times of the HKs are comparable to their one-compartment model estimates (Table 3) . The octanol/water partition coefficients of the HKs (5.3 for 1,1-dichloropropanone and 12.9 for 1,1,1-trichloropropanone) were approximately one order of magnitude lower than that of chloroform, 93 (Hansch et al., 1995; Xu and Weisel, 2003) . Thus, a smaller percentage of the HKs absorbed via inhalation would partition from the blood to the peripheral tissues than chloroform. This might explain the similar blood residence times of the HKs calculated from the singleand biexponential equations. Therefore, a single exponential decay process (one-compartment) may be adequate to describe the HK postexposure breath concentration profiles.
The uptake-phase blood residence time values of the DBPs were calculated for each subject (Table 4 ). The average blood residence times for chloroform. 1,1-dichloropropanone, and 1,1,1-trichloropropanone are 2.5472.98, 4.4672.76, and 6.6073.39 min, respectively. The residence time of 1,1,1-trichloropropanone estimated from postexposure data (Table 3) is similar to the value obtained by this method. The decay-phase estimate of the time for 1,1-dichloropropanone (Table 3) is approximately 1.5 times the uptake-phase estimate. However, the blood residence time of chloroform based on decay-phase data and biexponential decline (6.86 min. Table 3 ) is approximately three times higher than the value calculated from uptake-phase data. The literature value of residence time of chloroform in the blood compartment has a wide range from 1 to 7 min (Weisel et al., 1992; Pleil and Lindstrom, 1997; Raymer et al., 1991; Wallace et al., 1991) .
Extrapolation of Breath DBP Concentration
The maximum breath concentration immediately following the exposure can be extrapolated from the single exponential model (Eq. (9), C alv max ) and from the biexponential model (Eq. (10), A þ B). The population mean value of C alv max was close to the value calculated using the biexponential model (A þ B) for each of the DBPs. The extrapolated mean breath concentrations at t ¼ 0 following exposure are approximately 10, 0.3, and 1.0 mg/m 3 for chloroform, 1,1-dichloropropanone, and 1,1,1-trichloropropanone, respectively.
The breath concentration at the end of exposure was not measured in the study. However, the breath concentration just before the subjects left the shower stall are expected to be equal or slightly greater than the breath concentrations measured at 25 min during exposure because the breath concentrations of the DBPs approached a steady state from 10 to 25 min during the exposures (Figure 2 ). The expected breath concentrations of the DBPs at the end of exposure are approximately 50, 7, and 5 mg/m 3 for chloroform, 1,1-dichloropropanone, and 1,1,1-trichloropropanone, respectively. There appears a significant difference between the breath concentration just before exposure ends and the extrapolated breath concentration at the beginning of the postexposure period. A reasonable explanation for the difference has been given by Yu and Weisel (1996) . They claim that a discontinuity in the breath concentration should be observed at the end of inhalation exposure because the arterial blood concentration exceeds the venous blood concentration at this time point.
Absorbed Dose and Expired Amount
Respiratory uptake of the DBPs during the 30-min experiment was estimated for each subject. Since the subjects were at rest during the experiment a sedentary alveolar ventilation rate for dose estimates was used. Approximately 10-15 mg of chloroform and 4-6 mg of the haloketones were absorbed by the subjects via inhalation (Table 5 ). These internal doses correspond to about 0.6-0.9 mg/mg/L for chloroform and 0.2 mg/mg/L for the haloketones when normalized to water concentrations. The greater internal dose for chloroform per mg/L than haloketones reflects its greater evaporation from water even though it is less efficiently absorbed across the lungs. The normalized absorbed doses of the HKs during the 30-min inhalation exposure were comparable to each other and approximately one fourth of the dose of chloroform.
The amount of expired, unchanged DBP after exposure was calculated based on the area under the postexposure breath concentration curve and the individual alveolar ventilation rate (Table 1 ). The average areas under the postexposure breath concentration curves were estimated by fitting the measured postexposure breath concentrations using mixed effect models (Figure 3 ). The amount expired per microgram per liter of water after inhalation exposure was 0.02-0.06 mg for chloroform, approximately 6 Â 10 À4 mg for DCP and 7 Â 10 À4 mg for TCP (Table 6 ). The amount of chloroform expired after the 30-min inhalation exposure in the shower stall was between 2% and 9% of the internal dose for participants, whereas the amounts of the HKs expired were approximately 0.3-0.4% of their internal doses during exposure. Therefore, the majority of the absorbed DBPs were metabolized by the body.
Under the shower conditions used, the inhalation absorption doses were also estimated for more typical shower durations, 10 and 15 min, which represent the US EPA recommended values for the average and 50th percentile shower times, respectively, for the general population in the US (Table 5) (US EPA, 1996) . In the present experiments, the subjects were asked to stand close to the shower water stream without washing themselves, limiting their physical activities and therefore breathing rate. However, during an actual shower, washing activities and general movements within the shower stall would result in a higher inhalation rate than the sedentary inhalation rates used for the 30-min experimental shower conditions. Therefore, an inhalation rate of 14 L/min was selected for calculating the inhalation doses during actual showering. Approximately 10-20 mg of chloroform and 3-7 mg of the haloketones will be absorbed by the subjects through an inhalation route during a 10-15 min slower. These inhalation dose estimates for chloroform are about equivalent to ingesting 0.5 -1.4 L of drinking water with the same chloroform concentration as the shower water. Based on a breathing rate of 14 L/min for a 70-kg, male adult, Jo et al. (1990a) demonstrated that inhalation exposure to chloroform from a 10-min shower (401C) was equivalent to ingesting 0.7 L of the water.
Calculations based on in vitro data suggest that the potential HK doses of inhalation exposure during a 10-min shower for the same shower stall as used in this study could contribute approximately 20-30% of the daily HK ingestion dose assuming the inhalation rate is 14 L/min (Xu and Weisel, 2003) . The present calculations show that a 10-15 min shower can produce an internal dose of the HK equivalent to ingesting, 0.1-0.3 L of the drinking water (Table 5) , comparable to the previous estimates. The overall daily inhalation exposure in a house is expected to he greater than the estimates here due to the transport of the DBPs from shower air to household air.
Conclusions
The exhaled breath concentrations of 1,1-dichloropropanone and 1,1,1-trichloropropanone were measurable during and immediately following inhalation exposure during a shower for the six selected human subjects. The air to breath concentration ratio during exposure was higher for HKs than for chloroform, indicating that the HKs are absorbed across the lungs more efficiently than chloroform. The lower breath concentrations for the HKs than for chloroform are consistent with their greater solubility in water and blood than in air than chloroform. Based on the dose calculations, the respiratory uptake of HKs during showering is about 1 4 to 1 3 that of chloroform. The internal dose of the HKs from a typical shower was equivalent to ingesting about 0.1-0.3 L of the drinking water. Therefore, inhalation absorption may be an important exposure route for the HKs. A small portion of the absorbed dose was expired after exposure, indicating that the majority of the dose is metabolized in human body. These data can be used to evaluate total exposure and associated health risk of the DBPs in drinking water. Further studies with a larger sample size (human subjects) are needed to extrapolate these results to the general population. to the Agency's review and therefore does not necessarily reflect the views of the Agency. Clifford P. Weisel is supported in part by the NIEHS Center for Excellence Grant (ES05022-06).
